Quantitative measurement of skeletal alkaline phosphatase to be used as an aid in the management of patients with Paget disease and osteoporosis
Immediatley following collection, mix sample by gently inverting 5 times
Gold serum separator (SST) tube
Ambient (preferred) - 14 days
Refrigerated - 14 days
Frozen - 14 days
Freeze/thaw cycles - stable x3
Immunochemiluminometric (ICMA)
Age | Male (μg/L) | Female (μg/L) |
0 to 5 m | Not established | Not established |
6 to 11 m | 48.2−170.2 | 50.4−154.0 |
1 y | 41.9−229.6 | 44.2−178.3 |
2 y | 41.7−139.4 | 34.9−195.4 |
3 to 4 y | 37.2−127.7 | 37.4−96.8 |
5 to 6 y | 42.0−104.2 | 31.4−100.8 |
7 to 8 y | 59.0−101.3 | 44.0−135.8 |
9 to 10 y | 50.4−133.0 | 47.9−150.8 |
11 to 12 y | 53.3−156.8 | 24.2−133.3 |
13 to 14 y | 77.5−169.8 | 19.8−92.7 |
15 to 16 y | 26.8−173.4 | 11.2−30.2 |
17 to 18 y | 15.4−69.8 | 8.8−29.0 |
19 to 20 y | 12.2−36.6 | 7.7−16.8 |
21 to 29 y | 7.4−27.7 | See below |
30 to 34 y | 7.0−27.4 | See below |
35 to 39 y | 4.0−27.0 | See below |
40 to 44 y | 7.4−26.7 | See below |
45 to 49 y | 7.5−26.4 | See below |
50 to 54 y | 7.5−26.1 | See below |
55 to 59 y | 7.5−25.7 | See below |
60 to 64 y | 7.5−25.4 | See below |
65 to 69 y | 7.6−25.1 | See below |
70 to 74 y | 7.6−24.8 | See below |
75 to 100 y | 7.6−24.4 | See below |
Premenopausal | 6.0−22.7 μg/L | |
Postmenopausal | 8.1−31.6 μg/L |